"The pipeline is richer these days; however, it is too soon to say whether the industry has found the right solution yet."
Jon Howells, PA pharmaceutical industry expert
Mandag Morgen magazine has undertaken a thorough analysis of the global pharmaceutical market and how it will respond to an ageing population and a growing middle class. In the article, PA’s Jon Howells, pharmaceutical industry expert, comments on the development of the industry, and its prospects.
“The pipeline is richer these days; however, it is too soon to say whether the industry has found the right solution yet. Quick gains were made in the 1980s and 1990s, and today it has become more of a challenge to deal with complex diseases such as cancer,” says Jon, adding that the number of pharma companies will be markedly reduced in five to ten years.
According to Jon, the pharmaceutical industry needs to become better at demonstrating its actual value to society, especially in the light of the current financial crisis, where there is an increasing need for new types of medicine that are safe and efficient against illnesses: “There is still a long way ahead; however, the industry is capable of delivering better results and showing its value in society. This requires a more holistic approach to treatment, which will help the industry improve the trust from clients and patients.”